• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

The Macro View – Health, Economics, and Politics and the Big Picture. What I Am Watching Here And Abroad.
October 06, 2022 Edition-----In the UK the current Tory Government appears to have totally lost the plot and failed to even move to fix things – a real disaster I fear for millions.In the US Hurricane Ian seems to have been of Biblical Scale that will take years to repair the damage.In Europe we see the recession arriving.In OZ we are coping with the Optus data breach, an imminent and difficult Budget and the new Integrity Commission being sorted out!-----Major Issues.-----https://www.afr.com/technology/manufacturers-turn-to-robots-as-job-ads-go-unanswered-20220920-p5bjilHow a $1m robot solved this company ’s labour sh...
Source: Australian Health Information Technology - October 6, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs

Weekly Australian Health IT Links – 15 August, 2022.
Here are a few I have come across the last week or so. Note: Each link is followed by a title and a few paragraphs. For the full article click on the link above title of the article. Note also that full access to some links may require site registration or subscription payment.General Comment-----Interesting to see ongoing funding for the #myHR announced to help Accenture keep is all going. Not sure why?Lots of NBN news with the Annual Report released.-----https://itwire.com/business-it-news/security/ransomware-attacks-on-the-rise-report.htmlThursday, 11 August 2022 15:33Ransomware attacks on the rise: reportBy Staff Write...
Source: Australian Health Information Technology - August 15, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs

Fight Aging! Newsletter, May 2nd 2016
This study is the first CAR T-cell trial to infuse patients with an even mixture of two types of T cells (helper and killer cells, which work together to kill cancer). With the assurance that each patient gets the same mixture of cells, the researchers were able to come to conclusions about the effects of administering different doses of cells. In 27 of 29 participants whose responses were evaluated a few weeks after the infusion, a high-sensitivity test could detect no trace of their cancer in their bone marrow. The CAR T cells eliminated cancers anywhere in the body they appeared. Of the two participants who did n...
Source: Fight Aging! - May 1, 2016 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs